To a company committed to developing and commercializing new medicines for patients battling cancer itself this is a pretty good year for $VSTM starting the year at 1.3 then its peak at 4.21 last 4/22 and now still fighting their way up ., looking back on Aug 30 2018 were they reached 9.97, in my opinion, they can do it again,. better watch this one out